HORIZON Research and Innovation Actions

Funded by European Health and Digital Executive Agency

01/09/2022 - 31/08/2027 (5 years)

Oslo Universitetssykehus HF, Norway

VIEW PARTNERS >
View website

Oslo Universitetssykehus HF, Norway

Fondazione Irccs Istituto Nazionale Dei Tumori, Italy

Vrije Universiteit Brussel, Belgium

Fundación para la Investigación Del Hospital Clínico De La Comunitat Valenciana, Fundacion INCLIVA, Spain

Region Hovedstaden, Denmark

Klinikum Ernst Von Bergmann Gemeinnutzige GMBH, Germany

Fundatia Hospice Casa Sperantei, Romania

DNV IMATIS AS, Norway

European Association of Palliative Care, Belgium

European Cancer Patient Coalition, Belgium

Accelopment Schweiz AG, Switzerland

European Society for Medical Oncology, Switzerland

The University of Edinburgh, United Kingdom

University of Leeds, United Kingdom

The Leeds Teaching Hospitals National Health Service Trust, United Kingdom

Why it matters

MyPath can significantly improve the quality of and access to treatment and care, reduce variations in clinical practice, and optimise resources in family, community, and hospital care settings. This will ultimately reduce the physical, emotional, and ultimately economic burden linked to cancer.

What ECPC does

ECPC will participate in three work packages. It will be an essential contributor to co-design the structure and contents besides in the dissemination and communication of the project. ECPC will also have a major role in the coordination and the networking of the consortium.

EU flag logo

This project is funded by the European Union under Grant Agreement No 101057514.